Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ferric Carboxymaltose in Orthopedic Surgery Patients at High Risk of Blood Loss
2010-024115-14Phase 4Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoint: Units of packed red blood cells per patient. Started Mar 2011; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2010-024115-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024115-14.